Who owns LEXARIA BIOSCIENCE?
- Ticker: LEXX
- CUSIP Number: 52886n406
Tip: Access positions for across all investors
Analyze quarterly positions in Lexaria Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lexaria Bioscience stock
Who bought or sold LEXARIA BIOSCIENCE this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Invenomic Capital Management | 471k | $291k | -1% | Dec 2025 |
|
| UBS Group | 361k | $223k | 4996% | Dec 2025 |
|
| Vanguard Group | 259k | $160k | 0% | Dec 2025 |
|
| Geode Capital Management | 220k | $136k | 26% | Dec 2025 |
|
| State Street Corporation | 39k | $24k | 0% | Dec 2025 |
|
| BlackRock | 27k | $17k | 0% | Dec 2025 |
|
| Krilogy Financial | 20k | $19k | 0% | Mar 2026 |
|
| Northern Trust | 18k | $11k | 0% | Dec 2025 |
|
| Renaissance Technologies | 16k | $9.6k | 54% | Dec 2025 |
|
| Advisor Group Holdings | 2.2k | $1.4k | 0% | Dec 2025 |
|
| Byrne Asset Management | 800.00 | $624.000000 | -99% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 382.00 | $232.981800 | 0% | Dec 2025 |
|
| MAI Wealth Advisors | 200.00 | $124.000000 | 100% | Dec 2025 |
|
| Farther Finance Advisors | 166.00 | $144.005000 | 0% | Mar 2026 |
|
| Tower Research Capital | 32.00 | $20.000000 | -99% | Dec 2025 |
|
| Gables Capital Management | 13.00 | $9.999600 | 0% | Mar 2026 |
|
| SBI Securities | 1.00 | $1.000000 | 100% | Mar 2026 |
|
Who sold out of Lexaria Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Murchinson | Sep 2025 | 420k | $400k |
| Virtu Financial | Sep 2025 | 29k | $28k |
| Rockefeller Capital Management | Sep 2025 | 200.00 | $191.000000 |
| Pnc Financial Services | Sep 2025 | 6.00 | $6.000000 |